Subtype
Retinal Cell Neoplasm
CI-CAN-00001460Explore in graph →
Non-malignant15 active trials1 approved drugs2 evidence items
- NCIt
- C7061
Loading cancer entity…
Subtype
CI-CAN-00001460Explore in graph →
Clinical trials
110 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05650749 | GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma and Metastatic Retinoblastoma(GPC2) | enrolling by invitation | Phase 1 | 45 | Stephan Grupp MD PhDOTHER | 1 | Aug 14, 2026 | clinicaltrials |
| NCT06227962 | Cognitive Functioning and Health Related Quality of Life in Retinoblastoma Survivors(RbNeuroQoL) | enrolling by invitation | — | 240 | Amsterdam University Medical CenterOTHER | 1 |
| Dec 4, 2025 |
| clinicaltrials |
Data updated 22 days agoSource updated Aug 14, 2026source: clinicaltrials